A New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2
Laboratory Medicine · 2023
DOI: 10.1093/labmed/lmac093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2023. Verfasst von Jing Tian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, People's Liberation Army Southern Theater Command, Guangzhou, China. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Technology Development Program of Shandong Province, China Postdoctoral Science Foundation, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Objective
The outbreak of COVID-19 caused by SARS-CoV-2 has led to a serious worldwide pandemic. Quantitative reverse transcription–polymerase chain reaction (qRT-PCR)–based methods were recommended for routine detection of SARS-CoV-2 RNA. Because the reaction time and analytical sensitivity of qRT-PCR limits the diagnosis of SARS-CoV-2, development of a quick process of SARS-CoV-2 detection technology with high analytical sensitivity remains urgent.
Methods
We combined isothermal amplification and fluorescence detection technology to develop a new auto-recombinase polymerase amplification (RPA)-fluorescence platform that could be used in the diagnosis of SARS-CoV-2.
Results
By optimization of primers and probes, the RPA platform could detect SARS-CoV-2 nucleotides within 15 min. The limits of detection and specificity of the auto-RPA-fluorescence platform were 5 copies/µL and 100%, respectively. The accuracy of detection of the auto-RPA-fluorescence platform in the 16 positive samples was 100%.
Conclusion
The RPA platform is a potential technology for the diagnosis of SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centers for Disease Control and Prevention, People's Liberation Army Southern Theater Command, Guangzhou, China.
- Laboratory of Medical Mycology, Jining No. 1 People's Hospital, Jining, China.
- Computational Bioscience Research Center (CBRC), Computer, Electrical and Mathematical Sciences and Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia.
- Jining Precision Medical Test Center, Jining No. 1 People's Hospital, Jining, China.
- Medical Laboratory Department, Jining No. 1 People's Hospital, Jining, China.
- Institute of Clinical Pharmacy & Pharmacology, Jining No. 1 People's Hospital, Jining, China.
Förderung
- Technology Development Program of Shandong Province
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
Zitieren
APA
Tian, J., Chen, B., Zhang, B., Li, T., Liang, Z., Guo, Y., Jiao, H., Liang, F., Xiang, L., Lin, F., Ren, R., & Liu, Q. (2023). A New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2. Laboratory Medicine. https://doi.org/10.1093/labmed/lmac093
Vancouver
Tian J, Chen B, Zhang B, Li T, Liang Z, Guo Y, et al. A New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2. Laboratory Medicine. 2023. doi:10.1093/labmed/lmac093
BibTeX
@article{Tian2023,
author = {Tian, Jing and Chen, Biao and Zhang, Bin and Li, Tantan and Liang, Zhiqiang and Guo, Yujin and Jiao, Huping and Liang, Fenghong and Xiang, Longquan and Lin, Fanzhong and Ren, Ruiwen and Liu, Qingbin},
title = {A New Auto-RPA-Fluorescence Detection Platform for SARS-CoV-2},
journal = {Laboratory Medicine},
year = {2023},
doi = {10.1093/labmed/lmac093}
}
EUVIMED